Anti-β-Alzheimer Therapies are aimed at tackling some of the major problems occurring in the treatment of Alzheimer’s disease (AD)

Anti-β-Alzheimer Therapies are aimed at tackling some of the major problems occurring in the treatment of Alzheimer’s disease (AD)



Anti-β-Alzheimer Therapies, also known as AAT, is a form of treatment that addresses the decline that occurs in the brain function of an individual suffering from Alzheimer's disease. The disease, first identified by Dr. Alzheimer (RETncer Alzheimer) in 1900, kills off the nerve cells in the brain and eventually destroys all memory. Alzheimer's is a genetic disease and is usually brought on by the attack of a particular protein known as amyloid in the brain. The amyloid proteins develop plaques, tangles, and fibers within the brain which cause it to deteriorate and ultimately fail.


Anti-β-Alzheimer Therapies treatments are given to patients in a medical doctor's office or clinic. These treatments generally take about half an hour to perform and most are administered with the use of a local anesthetic. The process of delivering the drug and its effects are very complex so that the doctor has to be under strict supervision to do it properly. The patient is made comfortable and is monitored at all times while the drug is being administered. For instance, in February 2021, researchers from the University of Bonn, Germany, carried out a clinical trial on mice that were deficient in major molecules of the immune system, were not able to secrete beta-antibodies which are necessary to combat Alzheimer’s disease. This is a very intensive treatment that involves a lot of skillful maneuvering. It may take several days to complete one AAT.

For the patient to feel as comfortable as possible during the procedure, medicine is normally administered intravenously. The doctor then places a cool, cloth-covered gel onto the IV. This cool cloth is placed directly on the skin, to prevent ice from melting and to keep the patient sedated. When the gel is ready, it is taken out of the IV and given directly to the patient.

There are many forms of anti-β-Alzheimer therapies available for patients who have been diagnosed with dementia. The first step is usually a consultation with a neurosurgeon to determine the best course of treatment for the patient. After the initial consultation, the physician will evaluate the case and write down all of the patient's information, as well as a paper detailing his or her symptoms. Then, the physician will decide which form of treatment is appropriate.

Post a Comment

Previous Post Next Post